Butylphthalide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Butylphthalide
Accession Number
DB12749
Description

Butylphthalide has been used in trials studying the prevention of Restenosis.

Type
Small Molecule
Groups
Investigational
Purchasing individual compounds or compound libraries for your research?
Learn More
Structure
Thumb
Weight
Average: 190.2384
Monoisotopic: 190.099379692
Chemical Formula
C12H14O2
Synonyms
  • 3-n-butylphthalide

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabThe risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab.
AceclofenacThe risk or severity of bleeding can be increased when Aceclofenac is combined with Butylphthalide.
AcemetacinThe risk or severity of bleeding can be increased when Acemetacin is combined with Butylphthalide.
AcenocoumarolThe risk or severity of bleeding can be increased when Butylphthalide is combined with Acenocoumarol.
Acetylsalicylic acidAcetylsalicylic acid may increase the antiplatelet activities of Butylphthalide.
AlclofenacThe risk or severity of bleeding can be increased when Alclofenac is combined with Butylphthalide.
AldesleukinThe risk or severity of bleeding can be increased when Butylphthalide is combined with Aldesleukin.
AlemtuzumabThe risk or severity of bleeding can be increased when Butylphthalide is combined with Alemtuzumab.
AlteplaseThe risk or severity of bleeding can be increased when Butylphthalide is combined with Alteplase.
AltretamineThe risk or severity of bleeding can be increased when Butylphthalide is combined with Altretamine.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzofuranones. These are organic compounds containing a benzene ring fused to a furanone.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Benzofurans
Sub Class
Benzofuranones
Direct Parent
Benzofuranones
Alternative Parents
Phthalides / Benzenoids / Lactones / Carboxylic acid esters / Oxacyclic compounds / Monocarboxylic acids and derivatives / Organooxygen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Aromatic heteropolycyclic compound / Benzenoid / Benzofuranone / Carboxylic acid derivative / Carboxylic acid ester / Hydrocarbon derivative / Isobenzofuranone / Isocoumaran / Lactone / Monocarboxylic acid or derivatives
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
822Q956KGM
CAS number
6066-49-5
InChI Key
HJXMNVQARNZTEE-UHFFFAOYSA-N
InChI
InChI=1S/C12H14O2/c1-2-3-8-11-9-6-4-5-7-10(9)12(13)14-11/h4-7,11H,2-3,8H2,1H3
IUPAC Name
3-butyl-1,3-dihydro-2-benzofuran-1-one
SMILES
CCCCC1OC(=O)C2=C1C=CC=C2

References

General References
Not Available
Human Metabolome Database
HMDB0032064
PubChem Compound
61361
PubChem Substance
347828938
ChemSpider
55293
RxNav
1484499
ChEMBL
CHEMBL248594
Wikipedia
Butylphthalide

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4RecruitingPreventionCerebral Infarctions / Collateral Circulation / Large-artery Occlusion1
4RecruitingTreatmentAcute Ischemic Stroke (AIS)1
4Unknown StatusPreventionStroke / Transient Ischemic Attack (TIA)1
3CompletedPreventionRestenosis1
3Not Yet RecruitingDiagnosticIschemic Cerebral Infarction / Ischemic Cerebrovascular Accident / Moyamoya Disease / Stroke, Ischemic / Transient Ischemic Attack (TIA)1
3RecruitingTreatmentAcute Ischemic Stroke (AIS)1
3RecruitingTreatmentDementia, Vascular1
2, 3Unknown StatusTreatmentVascular Cognitive Impairment no Dementia1
Not AvailableRecruitingTreatmentCerebral Small Vessels Disease1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0654 mg/mLALOGPS
logP3ALOGPS
logP3.36ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)15.7ChemAxon
pKa (Strongest Basic)-6.9ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area26.3 Å2ChemAxon
Rotatable Bond Count3ChemAxon
Refractivity54.78 m3·mol-1ChemAxon
Polarizability21.29 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on October 20, 2016 18:01 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates